Abstract
HIV infections in Peru are concentrated among men who have sex with men (MSM) and transgender women (TW). HIV testing rates among them remain low, delaying entrance into care. We assessed the prevalence of frequent HIV testing (at least every 6 months) and associated factors among 310 MSM and TW who attend sexual health clinics in Lima, Peru, and who reported that they were HIV seronegative or unaware of their status. Only 39% of participants tested frequently, and 22% had never tested; 29% reported that they were at low or no risk for acquiring HIV. Reporting low or no risk for acquiring HIV was associated with frequent testing (adjusted prevalence ratio [aPR]=1.53, 95% CI, 1.13–2.08); those reporting unprotected anal sex were less likely to test frequently (aPR=0.66, 95% CI, 0.50–0.87). HIV prevalence was 12% and did not vary by risk perception categories. This at-risk population tests infrequently and may not understand the risk of having unprotected sex.
Keywords: HIV, MSM, HIV testing, risk perception, Peru
Resumen
Las infecciones por el VIH en el Perú se concentran entre hombres-que-tienen-sexo-con-hombres (HSH) y mujeres transgénero (MT). El tamizaje de VIH entre ellos se mantiene bajo, retrasando la atención y el cuidado. Se evaluó la prevalencia de “tamizaje frecuente” para VIH (hacerse la prueba al menos cada 6 meses) y factores asociados en 310 HSH/MT que se atendieron en clínicas de salud sexual en Lima, Perú, y reportaron ser VIH-negativo o desconocer su status. Sólo 39% de los participantes reportaron tamizaje frecuente y 22% nunca se realizó una prueba de VIH. 29% reportó sentirse en bajo riesgo o no sentirse en riesgo de adquirir VIH. Reportar bajo o ningún riesgo de contraer VIH estuvo asociado al tamizaje frecuente (razón de prevalencia ajustada [RPa]: 1,53; IC del 95%: 1.13 a 2.8); Reportar sexo anal sin protección disminuye el tamizaje frecuente (RPa: 0,66; IC del 95%: 0,50–0,87). La prevalencia total de VIH fue 12% y no varió según las categorías de percepción de riesgo. Esta población en riesgo no se realiza tamizaje frecuentemente y quizá no comprenden el riesgo de tener sexo sin protección.
Introduction
By the first quarter of 2017, the number of HIV and AIDS cases in Peru reached 68,201 and 35,847, respectively, according to official reports of the National Center for Epidemiology, Prevention and Control of Diseases,[1] with more than 50% of cases occurring among men who have sex with men (MSM) and transgender women (TW).[2] Approximately 20% of MSM [3,4] and 30% of TW are HIV infected, with little change in prevalence over the past decade.[5] The incidence of new infection remains about 3 per 100/person-years despite the introduction of antiretroviral therapy (ART).[6,7]
The Peruvian national HIV prevention plan focuses on promotion of HIV testing under the assumption that persons identified as seropositive will be rapidly referred for care and treatment, which are free and government sponsored.[8] However, studies from Peru and the Andean region have shown a low uptake of HIV testing among MSM [9–11]; consequently, many are unaware of their HIV status.[6,12,13] Factors such as poor knowledge of HIV and feelings of being stigmatized and discriminated against have been associated with delayed or infrequent testing.[11,14]
The relationship of risk perception to HIV testing among MSM and TW has been evaluated in multiple settings, and the results have been mixed. Studies from the United States and China have shown that MSM who perceived themselves at higher risk of HIV were less likely to test,[15,16] whereas a study among MSM in Seattle found that those with higher perceived risk were more likely to test.[17] To better understand factors associated with HIV testing in Peru, particularly the perception of risk for HIV acquisition, we evaluated MSM and TW who were attending sexually transmitted infection (STI) clinics in Lima, the capital city.
Methods
Study population
We analyzed data collected from the baseline assessment of participants enrolled in PICASSO, a longitudinal cohort study designed to evaluate the prevalence and acquisition of syphilis among MSM and TW in Lima; study methods have been described in detail elsewhere.[18] In brief, from June 2013 through May 2014, MSM and TW attending two STI clinics in the city were invited to participate. Participants had to be aged ≥18 years and at high risk for syphilis acquisition, defined as having at least 3 of the following risk factors: (1) 5 years of sexual activity, (2) more than 5 sex partners during the preceding 3 months, (3) more than 5 episodes of condomless anal intercourse during the preceding 6 months, (4) a self-reported genital ulcer at recruitment, (5) self-report of a syphilis diagnosis in the preceding 2 years, (6) self-report of an STI diagnosis in the preceding 6 months, and (7) self-report of being HIV seropositive. Subjects willing to participate signed informed-consent forms and received 15 soles ($5) as reimbursement for the cost of transportation.
The PICASSO study recruited a total of 401 MSM and TW. Of these, 310 (77.3%) were included in the current analyses because they reported being HIV seronegative (N=243) or were unaware of their HIV status (N=67). Participants in the PICASSO study who reported that they were HIV seropositive (N=91) were excluded from the current analysis. The ethical review board at Universidad Peruana Cayetano Heredia, Lima, approved the protocol.
Data collection
Participants completed a computer-assisted personal interviewing (CAPI) survey lasting 30 minutes that assessed sociodemographic characteristics, gender or identity, sexual orientation, sexual risk behavior in the preceding 3 months, self-reported current HIV status, and history of syphilis. We also grouped participants who indicated that their sexual identity was “heterosexual” (N=8) with those who were “bisexual” because the number of heterosexuals was small. Participants were asked how often they had undergone HIV testing and their perceived risk of acquiring HIV. Participants who indicated that they had tested at least every 6 months were considered “frequent HIV testers,” regardless of how many times they had tested. Participants reported their perceived risk of acquiring HIV as high, moderate, low, or no risk; we grouped participants who indicated that they had “no risk for HIV” (N=15) with those who reported “low risk” (N=75).
Venous blood samples were obtained for HIV and syphilis testing. At clinic sites, samples were tested for HIV with a third-generation rapid test (Determine HIV 1/2 Alere Determine™, Israel). Syphilis infection was evaluated by using a third-generation treponemal-specific antibody rapid test (Determine syphilis Alere Determine™, Israel) in parallel with a rapid plasma reagin (RPR) test (BD Macro-Vue™ RPR Card Test Kit, Beckton Dickinson, United States). Clients were told that results from rapid testing were preliminary and would be confirmed by further testing of samples at the reference laboratory. Participants also self-collected anal swab samples for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) testing.
All samples were sent to the Laboratory of Sexual Health, located at Universidad Peruana Cayetano Heredia, Lima, for confirmatory testing. Serum samples were rescreened for HIV using a fourth-generation enzyme immunoassay (EIA) test (Genscreen™ ULTRA HIV Ag-Ab, Bio-Rad, France); samples that were positive in an EIA or rapid test were confirmed using a western blot test (NEW LAV BLOT I, Bio-Rad, France). All samples were evaluated for the presence of syphilis by testing with the Treponema pallidum particle agglutination (TPPA) assay (Fujirebio Diagnostics, Tokyo, Japan). A participant was considered to have a recent syphilis infection if the RPR titer was ≥1:16 and the TPPA test was positive. We used a transcription mediated amplification (TMA) assay (Aptima Combo2 Assay, Gen-probe, United States) on anal swab samples to diagnose CT and GC. The confirmatory results of syphilis, HIV, CT, and GC testing were delivered to participants 2 weeks after sample collection. STIs were treated according to national guidelines [19]; those who were identified as being HIV seropositive were referred for further evaluation and care.
Data analysis
We evaluated the distribution of sociodemographic characteristics, sexual risk behavior in the preceding 3 months, and STIs and HIV infection, as well as the proportion of participants in each category who tested “frequently.” Differences in proportions among the categories were evaluated using the chi-square test. We evaluated the univariate and multivariable association of covariates with frequent HIV testing using prevalence ratios (PRs), as the frequency of the outcome was greater than 10% [20] and all data were cross-sectional. In multivariable models, we included age, monthly income, and presence of a stable sex partner a priori, as well as variables associated with frequent testing and a P value of <0.2 in univariate analysis. We used generalized linear models with a log link and Poisson robust error variance to calculate PRs.[20,21] Our modeling strategy was to group variables into sexual behavior (first subgroup) and sociodemographics (second subgroup). The effect of each significant variable within the sexual behavior subgroup was entered, then the significant variables of the sociodemographics subgroup. Finally, a priori variables were added. The multivariable model was evaluated after the addition of each variable. The selection criteria for inclusion of variables in the final model were based on choosing the regression model with lower values of the Akaike information criterion and the Bayesian information criterion that included a priori variables of importance. We also evaluated the association between sociodemographic and other variables and levels of risk perception using chi-square and Fisher exact tests, as appropriate. The association between self-reported history of syphilis and laboratory-confirmed syphilis infection was determined using chi-square tests.
Results
Approximately two thirds (68.1%) of recruited participants were aged 35 years or younger (Table 1). More than half (53.8%) self-identified as gay or homosexual, 24.2% as bisexual, and 22.0% as TW. Nearly two thirds (63.4%) earned more than the Peruvian monthly minimum wage of about 250 USD; 51.0% reported having had at least some postsecondary education. Eighty percent reported having more than 1 sex partner during the preceding three months, and almost the same proportion reported unprotected anal intercourse. About one third (31.9%) reported having had syphilis in the past; 28.4% had a laboratory-confirmed diagnosis of an STI, including anal chlamydia (14%), anal gonorrhea (9%), and recent syphilis infection (12%). Twenty-three percent of the entire sample considered themselves at high risk for HIV, 47.7% at moderate risk, and 29.0% at low or no risk. A total of 37 participants (12%) were found to be HIV infected. In subanalyses for which data are not shown, 11% (26 of 243) of those who reported themselves as HIV negative at enrollment were found to be HIV seropositive, and 16% (11 of 67) of those who did not know their HIV status were identified as being infected (P value <0.1). The proportion of MSM and TW who reported testing frequently was 39.3%. Participants reporting low or no HIV risk had a higher prevalence of frequent testing (55.6%) when compared with those who perceived themselves at moderate (29.7%) or high (38.9%) HIV risk. Variables related to testing frequently included being a TW, reporting 2 or more recent sex partners, being engaged primarily in receptive anal intercourse, having engaged in sex work, or reporting a previous syphilis infection.
Table 1.
Variable | All | Tested frequently | Test statistic | P value |
---|---|---|---|---|
N(%) | n(%) | |||
All | 310(100) | 122(39.3) | ||
Sexual orientation/gender identityb | X2=14.1, df=2 | .001 | ||
Gay/homosexual | 164(53.8) | 66(40.2) | ||
Bisexual/heterosexual | 74(24.2) | 18(24.3) | ||
Transgender woman | 67(22.0) | 37(55.2) | ||
Age (years) | X2=1.1, df=2 | .565 | ||
18–25 | 102(32.9) | 36(35.3) | ||
26–35 | 109(35.2) | 44(40.4) | ||
≥36 | 99(31.9) | 42(42.4) | ||
Monthly income (USD)b | X2=6.9, df=2 | .031 | ||
≤250 | 109(36.6) | 54(49.5) | ||
251–500 | 147(49.3) | 49(33.3) | ||
≥501 | 42(14.1) | 18(42.9) | ||
Education | X2=2.5, df=1 | .113 | ||
≤ High school | 152(49.0) | 53(34.9) | ||
> High school | 158(51.0) | 69(43.7) | ||
Perceived risk for HIV | X2=15.8, df=3 | <.001 | ||
High | 72(23.3) | 28(38.9) | ||
Moderate | 148(47.7) | 44(29.7) | ||
Low/none | 90(29.0) | 50(55.6) | ||
Number of sex partners, last 3 months | X2=7.2, df=2 | .028 | ||
0–1 | 62(20.0) | 16(25.8) | ||
2–4 | 82(26.5) | 39(47.6) | ||
≥5 | 166(53.5) | 67(40.4) | ||
Condomless anal intercourse, last 3 monthsb | X2=13.1, df=1 | <.001 | ||
Yes | 239(79.7) | 84(35.1) | ||
No | 61(20.3) | 37(60.7) | ||
Sex role during intercourse, last 3 months | X2=6.8, df=2 | .034 | ||
Insertive | 77(24.8) | 22(28.6) | ||
Receptive | 98(31.6) | 47(48.0) | ||
Insertive and receptive | 135(43.6) | 53(39.3) | ||
Had male/TW stable sex partner, last 3 months | X2=2.6, df=1 | .152 | ||
Yes | 147(47.4) | 64(43.5) | ||
No | 163(52.6) | 58(35.6) | ||
Had male/TW casual sex partner, last 3 months | X2=0.1, df=1 | .740 | ||
Yes | 159(51.3) | 64(40.3) | ||
No | 151(48.7) | 58(38.4) | ||
Performed sex work, last 3 months | X2=3.7, df=1 | .055 | ||
Yes | 62(20.0) | 31(50.0) | ||
No | 248(80.0) | 91(36.7) | ||
Self-reported history of syphilis, ever | X2=14.1, df=1 | <.001 | ||
Yes | 99(31.9) | 54(54.5) | ||
No | 211(68.1) | 68(32.2) | ||
Laboratory diagnosis of STIc | X2=0.5, df=1 | .497 | ||
Yes | 88(28.4) | 32(36.4) | ||
No | 222(71.6) | 90(40.5) | ||
Laboratory diagnosis of HIV | X2= 0.3, df=1 | .432 | ||
Positive | 37(11.9) | 13(35.1) | ||
Negative | 273(88.1) | 109(39.9) |
Testing frequently was defined as having tested at least every 6 months.
Small discrepancies in subtotals and totals are due to rounding and/or missing values.
Syphilis, rectal chlamydia, and/or rectal gonorrhea.
Factors independently associated with frequent HIV testing included having postsecondary education (aPR=1.38, 95% CI, 1.03–1.84); believing oneself to have little or no risk for HIV (aPR=1.53, 95% CI, 1.13–2.08), compared with feeling at moderate risk; reporting a history of syphilis (aPR=1.59, 95% CI, 1.23–2.06); and having 2 to 4 recent sex partners (aPR=1.73, 95% CI, 1.09–2.72) (Table 2). Having condomless anal intercourse was associated with being less likely to test frequently (aPR=0.66, 95% CI, 0.50–0.87).
Table 2.
Variables | PR(b) | 95% CI | z score | P value | aPRb | 95% CI | z score | P value | |
---|---|---|---|---|---|---|---|---|---|
Sexual orientation/gender identity | |||||||||
Gay/homosexual | Ref. | - | - | Ref. | - | - | |||
Bisexual/heterosexual | 0.60 | 0.39–0.94 | –2.22 | .026 | 0.77 | 0.48–1.24 | –1.06 | .291 | |
Transgender woman | 1.37 | 1.03–1.83 | 2.17 | .030 | 1.28 | 0.91–1.79 | 1.43 | .152 | |
Age (years) | |||||||||
18–25 | Ref. | - | - | Ref. | - | - | |||
26–35 | 1.14 | 0.81–1.62 | 0.76 | .450 | 1.04 | 0.73–1.46 | 0.20 | .839 | |
≥36 | 1.20 | 0.85–1.70 | 1.03 | .302 | 0.96 | 0.69–1.33 | –0.24 | .809 | |
Monthly income (USD) | |||||||||
≤250 | Ref. | - | - | Ref. | - | - | |||
251–500 | 0.67 | 0.50–0.91 | –2.61 | .009 | 0.76 | 0.57–1.01 | –1.92 | .055 | |
≥501 | 0.87 | 0.58–1.29 | –0.71 | .475 | 0.81 | 0.53–1.23 | –0.98 | .325 | |
Education | |||||||||
≤ High school | Ref. | - | - | Ref. | - | - | |||
> High school | 1.25 | 0.95–1.66 | 1.57 | .116 | 1.38 | 1.03–1.84 | 2.20 | .028 | |
Perceived risk for HIV | |||||||||
High | 1.31 | 0.89–1.92 | 1.38 | .168 | 1.02 | 0.71–1.46 | 0.11 | .913 | |
Moderate | Ref. | - | - | Ref. | - | - | |||
Low/none | 1.87 | 1.37–2.55 | 3.96 | <.001 | 1.53 | 1.13–2.08 | 2.77 | .006 | |
Number of sex partners, last 3 months | |||||||||
0–1 | Ref. | - | - | Ref. | - | - | |||
2–4 | 1.84 | 1.14–2.98 | 2.50 | .013 | 1.73 | 1.09–2.72 | 2.36 | .018 | |
≥5 | 1.56 | 0.99–2.48 | 1.90 | .058 | 1.49 | 0.94–2.36 | 1.71 | .086 | |
Condomless anal intercourse, last 3 months | |||||||||
Yes | 0.58 | 0.44–0.76 | –4.02 | <.001 | 0.66 | 0.49–0.87 | –3.01 | .003 | |
No | Ref. | - | - | Ref. | - | - | |||
Sex role during anal intercourse, last 3 months | |||||||||
Insertive | Ref. | - | - | Ref. | - | - | |||
Receptive | 1.68 | 1.11–2.53 | 2.48 | .013 | 1.04 | 0.66–1.62 | 0.17 | .865 | |
Insertive and receptive | 1.37 | 0.91–2.07 | 1.51 | .130 | 0.97 | 0.63–1.51 | –0.11 | .915 | |
Had male/TW stable sex partner, last 3 months | |||||||||
Yes | 1.22 | 0.93–1.61 | 1.43 | .154 | 1.2 | 0.93–1.56 | 1.43 | .152 | |
No | Ref. | - | - | Ref. | - | - | |||
Performed sex work, last 3 months | |||||||||
Yes | 1.36 | 1.01–1.83 | 2.03 | .042 | 1.21 | 0.89–1.65 | 1.20 | .229 | |
No | Ref. | - | - | Ref. | - | - | |||
Self-reported history of syphilis, ever | |||||||||
Yes | 1.69 | 1.29–2.21 | 3.87 | <.001 | 1.59 | 1.23–2.06 | 3.60 | <.001 | |
No | Ref. | - | - | Ref. | - | - | |||
Laboratory diagnosis of STIc | |||||||||
Yes | 0.89 | 0.65–1.23 | –0.67 | .505 | - | - | - | ||
No | Ref. | - | - | - | - | - | |||
Laboratory diagnosis of HIV | |||||||||
Positive | 0.88 | 0.55–1.39 | –0.54 | .588 | - | - | - | ||
Negative | Ref. | - | - | - | - | - | |||
|
Testing frequently was defined as having tested at least every 6 months.
PR = prevalence ratio, (a)PR = adjusted prevalence ratio.
Syphilis, rectal chlamydia, and/or rectal gonorrhea.
We analyzed the association of sociodemographic characteristics and sexual behavior with HIV risk perception (Table 3). Among those with less education, 27.0% reported being at high risk for HIV, compared with 19.6% of those who had postsecondary education. Among those reporting more than 4 recent sex partners, 30.7% felt at high risk for HIV, compared with 18.3% of those who had 2 to 4 sex partners and 17.7% of those with 1 or no recent sex partners. The proportion of MSM and TW who perceived themselves at high risk for HIV was higher among those who engaged in sex work compared with those who did not (32.3% vs 11.2%). There was no association between recently identified HIV infection and risk perception. A subanalysis among those who reported having had a syphilis infection showed that 65% had a positive TPPA test (data not shown).
Table 3.
Variable | N (%) | Perceived risk | Test statistic | P value | ||
---|---|---|---|---|---|---|
High | Moderate | Low/None | ||||
All | 310 (100) | 72 (23.3) | 148 (47.7) | 90 (29.0) | - | |
Sexual orientation/gender identitya | X2=8.5, df=4 | .075 | ||||
Gay/homosexual | 164 (53.8) | 33 (20.1) | 75 (45.7) | 56 (34.2) | ||
Bisexual/heterosexual | 74 (24.2) | 16 (21.6) | 43 (58.1) | 15 (20.3) | ||
Transgender woman | 67 (22.0) | 21 (31.3) | 29 (43.2) | 17 (25.4) | ||
Age (years) | X2=2.4, df=4 | .658 | ||||
18–25 | 102 (32.9) | 22 (21.6) | 50 (49.0) | 30 (29.4) | ||
26–35 | 109 (35.2) | 26 (23.9) | 56 (51.4) | 27 (24.7) | ||
≥36 | 99 (31.9) | 24 (24.2) | 42 (42.4) | 33 (33.4) | ||
Monthly income (USD)a | X2=4.5, df=4 | .346 | ||||
≤250 | 109 (36.6) | 27 (24.8) | 45 (41.3) | 37 (33.9) | ||
251–500 | 147 (49.3) | 36 (24.5) | 73 (49.7) | 38 (25.8) | ||
≥501 | 42 (14.1) | 6 (14.3) | 22 (52.4) | 14 (33.3) | ||
Education | X2=6.9, df=2 | .032 | ||||
≤ High school | 152 (49.0) | 41 (27.0) | 77 (50.7) | 34 (22.3) | ||
> High school | 158 (51.0) | 31 (19.6) | 71 (44.9) | 56 (35.4) | ||
Number of sex partners, last 3 months | X2=17.6, df=4 | .002 | ||||
0–1 | 62 (20.0) | 11 (17.7) | 28 (45.2) | 23 (37.1) | ||
2–4 | 82 (26.5) | 15 (18.3) | 32 (39.0) | 35 (42.7) | ||
≥5 | 166 (53.5) | 46 (27.7) | 88 (53.0) | 32 (19.3) | ||
Condomless anal intercoursea, last 3 months | X2=2.4, df=2 | .299 | ||||
Yes | 239 (79.7) | 57 (23.9) | 119 (49.8) | 63 (26.4) | ||
No | 61 (20.3) | 14 (23.0) | 25 (41.0) | 22 (36.1) | ||
Sex role during anal intercourse, last 3 months | X2=6.2, df=4 | .182 | ||||
Insertive | 77 (24.8) | 22 (28.6) | 38 (49.4) | 17 (22.0) | ||
Receptive | 98 (31.6) | 22 (22.5) | 40 (40.8) | 36 (36.7) | ||
Insertive and receptive | 135 (43.6) | 28 (20.7) | 70 (51.9) | 37 (27.4) | ||
Had male/TW stable sex partner, last 3 months | X2=5.4, df=2 | .067 | ||||
Yes | 147 (47.4) | 38 (25.8) | 60 (40.8) | 49 (33.3) | ||
No | 163 (52.6) | 34 (20.9) | 88 (54.0) | 41 (25.1) | ||
Performed sex work, last 3 months | X2=5.2, df=2 | .073 | ||||
Yes | 62 (20.0) | 20 (32.3) | 30 (48.4) | 12 (19.3) | ||
No | 248 (80.0) | 52 (21.0) | 118 (47.6) | 78 (31.4) | ||
Self-reported history of syphilis | X2=1.2, df=2 | .542 | ||||
Yes | 99 (31.9) | 26 (26.3) | 43 (43.4) | 30 (30.3) | ||
No | 211 (68.1) | 46 (21.8) | 105 (49.8) | 60 (28.4) | ||
Laboratory diagnosis of STIb | X2=0.3, df=2 | .981 | ||||
Yes | 88 (28.4) | 21 (23.8) | 42 (47.7) | 25 (28.5) | ||
No | 222 (71.6) | 51 (23.0) | 106 (47.8) | 65 (29.2) | ||
Laboratory diagnosis of HIV | X2=0.7, df=2 | .698 | ||||
Positive | 37 (11.9) | 8 (21.6) | 20 (54.1) | 9 (24.3) | ||
Negative | 273 (88.1) | 64 (23.4) | 128 (46.9) | 81 (29.7) |
Small discrepancies in subtotals and totals are due to rounding and/or missing values.
Syphilis, rectal chlamydia, and/or rectal gonorrhea.
Discussion
Even though MSM and TW are the key populations in the HIV epidemic in Peru, we found that only 39% of our sample reported testing for HIV every 6 months, as recommended by both international and national guidelines [19,22]; 20% of our sample had never had an HIV test. Several other studies had evaluated HIV testing behavior among MSM in Peru, and even though these studies were conducted 6 to 7 years before ours, the proportion of participants who had never had an HIV test was similar. In 2007, 15% of MSM who were enrolled from a STI clinic in Lima and 19% who were recruited from neighborhoods surrounding the city reported that they had never undergone HIV testing.[23] In 2008, only 6% of MSM who were recruited from low-income neighborhoods of Lima reported testing every 6 months, and 20% of the sample had never tested.[10] Among MSM responding to an internet-based survey in 2008, one half indicated that they had never tested.[24] Men who are sampled via an internet survey, however, may be less likely to test than those recruited from STI or other clinics, because HIV testing in Peru is provided almost exclusively at health care facilities. Overall, services and prevention messages targeting key populations in Peru remain limited in scope, which could help explain why rates of HIV testing do not appear to have changed much over time.
These results are concerning because a large proportion of our participants reported engaging in high-risk sexual behavior. In the past 3 months, about three quarters of our sample had more than 1 sex partner, and slightly more reported having unprotected anal intercourse. Some studies have shown that MSM who report more high-risk behavior are themselves more likely to test.[25,26] However, we found an inconsistent relationship between reported high-risk behavior and testing, which could be due to several factors, including an inaccurate perception of risk. For example, a high proportion of MSM and TW who had unprotected anal sex (primarily receptive sex) or a history of syphilis did not believe they were at high risk for HIV acquisition. It is possible that a lack of understanding of risk was due to low levels of knowledge, which could be the result of limited messaging about HIV prevention. In addition, factors that we did not measure may have contributed to how participants assessed their risk, such as knowledge of a partner’s HIV status.[13,27]
Overall, perceived risk has not been found to be a consistent predictor of testing behavior among MSM.[15–17, 28, 29]. In our study, there was an inverse relationship between perceived risk and frequent testing. It is likely that contextual factors also play a role in determining who seeks testing. For example, in our sample, MSM and TW with a history of syphilis may have been more likely to test for HIV because such testing is provided primarily at health facilities. In addition, MSM in Peru who already feel stigmatized for being gay may wish to avoid the additional discrimination that comes with being identified as HIV infected. This is consistent with a study of MSM and TW in New York City, in which those who said they would be stigmatized if identified as HIV infected were less likely to test.[29,30] In Peru, even though ART is widely available, it has been shown that HIV stigma may affect the adherence to treatment, affecting benefits of suppressed viral load.[31]
Our study had several limitations. First, our primary outcome measure—frequency of HIV testing—was based on its definition in the Peruvian HIV guidelines.[8] This definition is imprecise, however. We did not specify a time frame or the number of times someone needed to have tested to be considered a frequent tester. Second, we used only a single-item measure of HIV risk perception; more complex measures have been used to evaluate a broader range of dimensions of perceived risk.[32] Third, we did not ask questions about stigma or discrimination, which might have otherwise revealed whether fear of an HIV-positive test result and the potential stigma associated with it were related to avoidance of testing. Fourth, study participants were recruited at 2 STI clinics and screened for being at risk for syphilis infection, and therefore may not have been representative of MSM and TW who were not accessing care. Finally, our questionnaire was administered using CAPI to reduce social desirability bias, so we could not explore a more nuanced understanding of sexual and testing behavior or perceived risk.
Conclusions
Results from our study indicate that high-risk MSM and TW in Peru undergo HIV testing infrequently. Being unaware of their HIV status prevents those who are HIV infected from accessing treatment, for their own benefit as well as to reduce transmission to others.[33] Because testing in Peru is primarily facility-based, expansion to other venues and implementation of self-testing programs could increase coverage among this high-risk group.[34,35] Use of social media and more up-to-date information and communication methods could also encourage testing and treatment [36–40] as well as improve understanding of the importance of achieving an undetectable viral load.[41] Reducing stigma is complex and difficult, but engagement of HIV-infected MSM and TW in educational campaigns at the community level, and improving the sensitivity of health care providers, are still needed in Peru.[42–46] Overall, efforts to reach and to provide information and care to MSM and TW in Peru remain underresourced despite it being decades since the beginning of the HIV epidemic in this region. Even though the Peruvian Health Authorities proposed greater inclusion of gender and sexual minorities within the health services, interventions to ensure that this happens have not been implemented widely.[47]
Acknowledgments
This research was supported by US National Institute of Allergy and Infectious Diseases (R01AI099727-01). The authors express appreciation for the assistance of the Picasso project staff at the Universidad Peruana Cayetano Heredia, and the staff of the Epicentro Clinic and Barton MoH Center. We also wish to acknowledge all the participants of the Picasso Cohort. This article was partially prepared as part of the activities of the Masters in Epidemiologic Research offered jointly by the Universidad Peruana Cayetano Heredia (UPCH) and NAMRU-6, Peru. This program is part of the grant 2D43 TW007393 “Peru Infectious Diseases Epidemiology Research Training Consortium”, sponsored by the Fogarty International Center of the US National Institutes of Health (NIH/FIC). We wish to acknowledge the support from the University of California, San Francisco’s International Traineeships in AIDS Prevention Studies (US National Institute of Mental Health, R25 MH064712) and from the Starr Foundation Scholarship Fund. The authors are thankful for the support and guidance received from the faculty and fellow students of the program.
Funding: This study was funded by NIH/NIAID R-01 study #1R01AI099727-01.
Compliance with Ethical Standards
Disclosure of potential conflict of interests: Vargas S K declares that he has no conflict of interest; Konda K A declares that she has no conflict of interest; Leon S R declares that he has no conflict of interest; Brown B declares that he has no conflict of interest; Klausner J D declares that he has no conflict of interest; Lindan C declares that she has no conflict of interest; Caceres C F declares that he has no conflict of interest
Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent: Informed consent was obtained from all individual participants included in the study.
References
- 1.Ministerio de Salud, Peru [Ministry of Health, Peru] Centro Nacional De Epidemiología, Prevención Y Control De Enfermedades. Situación del VIH/SIDA en el Perú Boletín Epidemiológico Mensual MARZO 2017. 2017
- 2.Alarcon JO, Pun M, Gutierrez C, et al. Estimation and analysis of HIV incidence in the adult population in Peru: results of application of the MoT mathematical model. Rev Peru Med Exp Salud Publica. 2012;29(4):452–460. [DOI] [PubMed] [Google Scholar]
- 3.Sanchez J, Lama JR, Kusunoki L, et al. HIV-1, sexually transmitted infections, and sexual behavior trends among men who have sex with men in Lima, Peru. J Acquir Immune Defic Syndr. 2007;44(5):578–585. [DOI] [PubMed] [Google Scholar]
- 4.Passaro RC, Haley CA, Sanchez H, Vermund SH, Kipp AM. High HIV prevalence and the internet as a source of HIV-related service information at a community-based organization in Peru: a cross-sectional study of men who have sex with men. BMC Public Health. 2016;16(1):871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Silva-Santisteban A, Raymond HF, Salazar X, et al. Understanding the HIV/AIDS epidemic in transgender women of Lima, Peru: results from a sero-epidemiologic study using respondent driven sampling. AIDS Behav. 2012;16(4):872–881. [DOI] [PubMed] [Google Scholar]
- 6.Castillo R, Konda KA, Leon SR, et al. HIV and sexually transmitted infection incidence and associated risk factors among high-risk MSM and male-to-female transgender women in Lima, Peru. J Acquir Immune Defic Syndr. 2015;69(5):567–575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sanchez J, Lama JR, Peinado J, et al. High HIV and ulcerative sexually transmitted infection incidence estimates among men who have sex with men in Peru: awaiting for an effective preventive intervention. J Acquir Immune Defic Syndr. 2009;51(suppl 1):S47–S51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ministerio de Salud, Peru [Ministry of Health, Peru]. Norma Técnica de Salud para la Vigilancia Epidemiológica en Salud Pública de la Infección por el Virus de la Inmunodefiiencia Humana (VIH) y de las Infecciones de Transmisión Sexual (ITS) en el Perú. Lima, Peru; 2015. [Google Scholar]
- 9.Tabet S, Sanchez J, Lama J, et al. HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS. 2002;16(9):1271–1277. [DOI] [PubMed] [Google Scholar]
- 10.Lee SW, Deiss RG, Segura ER, et al. A cross-sectional study of low HIV testing frequency and high-risk behaviour among men who have sex with men and transgender women in Lima, Peru. BMC Public Health. 2015;15:408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Adam PC, de Wit JB, Toskin I, et al. Estimating levels of HIV testing, HIV prevention coverage, HIV knowledge, and condom use among men who have sex with men (MSM) in low-income and middle-income countries. J Acquir Immune Defic Syndr. 2009;52(suppl 2):S143–S151. [DOI] [PubMed] [Google Scholar]
- 12.Clark JL, Konda KA, Silva-Santisteban A, et al. Sampling methodologies for epidemiologic surveillance of men who have sex with men and transgender women in Latin America: an empiric comparison of convenience sampling, time space sampling, and respondent driven sampling. AIDS Behav. 2014;18(12):2338–2348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nagaraj S, Segura ER, Peinado J, et al. A cross-sectional study of knowledge of sex partner serostatus among high-risk Peruvian men who have sex with men and transgender women: implications for HIV prevention. BMC Public Health. 2013;13:181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Santos GM, Beck J, Wilson PA, et al. Homophobia as a barrier to HIV prevention service access for young men who have sex with men. J Acquir Immune Defic Syndr. 2013;63(5):e167–e170. [DOI] [PubMed] [Google Scholar]
- 15.MacKellar DA, Valleroy LA, Secura GM, et al. Perceptions of lifetime risk and actual risk for acquiring HIV among young men who have sex with men. AIDS Behav. 2007;11(2):263–270. [DOI] [PubMed] [Google Scholar]
- 16.Fan W, Yin L, Qian HZ, et al. HIV risk perception among HIV negative or status-unknown men who have sex with men in China. Biomed Res Int. Volume 2014 (2014), 232451, 9 pages. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nelson KM, Thiede H, Hawes SE, et al. Why the wait? Delayed HIV diagnosis among men who have sex with men. J Urban Health. 2010;87(4):642–655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Deiss RG, Leon SR, Konda KA, et al. Characterizing the syphilis epidemic among men who have sex with men in Lima, Peru to identify new treatment and control strategies. BMC Infect Dis. 2013;13:426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ministerio de Salud, Peru [Ministry of Health, Peru]. Directiva sanitaria N° 030-MINSA/DGSP-v.01 “Directiva Sanitaria Para la Atención Médica Periódica a las/os Trabajadoras/es Sexuales y HSH.” 2009.
- 20.Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Coutinho LM, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica. 2008;42(6):992–998. [PubMed] [Google Scholar]
- 22.Centers for Disease Control and Prevention (CDC). HIV testing among men who have sex with men—21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep. 2011;60(21):694–699. [PubMed] [Google Scholar]
- 23.Perez-Brumer AG, Konda KA, Salvatierra HJ, et al. Prevalence of HIV, STIs, and risk behaviors in a cross-sectional community- and clinic-based sample of men who have sex with men (MSM) in Lima, Peru. PLoS One. 2013;8(4):e59072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Blas MM, Alva IE, Cabello R, Carcamo C, Kurth AE. Risk behaviors and reasons for not getting tested for HIV among men who have sex with men: an online survey in Peru. PLoS One. 2011;6(11):e27334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hoenigl M, Anderson CM, Green N, Mehta SR, Smith DM, Little SJ. Repeat HIV-testing is associated with an increase in behavioral risk among men who have sex with men: a cohort study. BMC Med. 2015;13:218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Williams-Roberts H, Chang Y, Losina E, Freedberg KA, Walensky RP. Frequent HIV testing among participants of a routine HIV testing program. Virulence. 2010;1(2):68–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Konda KA, Castillo R, Leon SR, et al. HIV status communication with sex partners and associated factors among high-risk MSM and transgender women in Lima, Peru. AIDS Behav. 2017;21(1):152–162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.MacKellar DA, Valleroy LA, Secura GM, et al. Unrecognized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men: opportunities for advancing HIV prevention in the third decade of HIV/AIDS. J Acquir Immune Defic Syndr. 2005;38(5):603–614. [DOI] [PubMed] [Google Scholar]
- 29.Golub SA, Gamarel KE. The impact of anticipated HIV stigma on delays in HIV testing behaviors: findings from a community-based sample of men who have sex with men and transgender women in New York City. AIDS Patient Care STDs. 2013;27(11):621–627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Krueger EA, Chiu CJ, Menacho LA, Young SD. HIV testing among social media-using Peruvian men who have sex with men: correlates and social context. AIDS Care. 2016: 28(10):1301–1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Valenzuela C, Ugarte-Gil C, Paz J, et al. HIV stigma as a barrier to retention in HIV care at a general hospital in Lima, Peru: a case-control study. AIDS Behav. 2015;19(2):235–245 J Int AIDS Soc. 2016;19(3 suppl 2):20799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Napper LE, Fisher DG, Reynolds GL. Development of the perceived risk of HIV scale. AIDS Behav. 2012;16(4):1075–1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Chow JY, Konda KA, Borquez A, et al. Peru’s HIV care continuum among men who have sex with men and transgender women: opportunities to optimize treatment and prevention. Int J STD AIDS. 2016;27(12):1039–1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lipsitz MC, Segura ER, Castro JL, et al. Bringing testing to the people — benefits of mobile unit HIV/syphilis testing in Lima, Peru, 2007–2009. Int J STD AIDS. 2014;25(5):325–331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Volk JE, Lippman SA, Grinsztejn B, et al. Acceptability and feasibility of HIV self-testing among men who have sex with men in Peru and Brazil. Int J STD AIDS. 2016;27(7):531–536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Blas MM, Menacho LA, Alva IE, Cabello R, Orellana ER. Motivating men who have sex with men to get tested for HIV through the internet and mobile phones: a qualitative study. PLoS One. 2013;8(1):e54012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Young SD, Cumberland WG, Nianogo R, Menacho LA, Galea JT, Coates T. The HOPE social media intervention for global HIV prevention in Peru: a cluster randomised controlled trial. Lancet HIV. 2015;2(1):e27–e32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Fonner VA, Denison J, Kennedy CE, O’Reilly K, Sweat M. Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database Syst Rev. 2012;9:CD001224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5(6):e11068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Montaner JS, Lima VD, Harrigan PR, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as Prevention” experience in a Canadian setting. PLoS One. 2014;9(2):e87872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160–1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Grossman CI, Stangl AL. Editorial: Global action to reduce HIV stigma and discrimination. J Int AIDS Soc. 2013;16(3 suppl 2):18881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Berkley-Patton JY, Moore E, Berman M, et al. Assessment of HIV-related stigma in a US faith-based HIV education and testing intervention. J Int AIDS Soc. 2013;16(3 suppl 2):18644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Jain A, Nuankaew R, Mongkholwiboolphol N, et al. Community-based interventions that work to reduce HIV stigma and discrimination: results of an evaluation study in Thailand. J Int AIDS Soc. 2013;16(3 suppl 2):18711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.van der Elst EM, Smith AD, Gichuru E, et al. Men who have sex with men sensitivity training reduces homoprejudice and increases knowledge among Kenyan healthcare providers in coastal Kenya. J Int AIDS Soc. 2013;16(suppl 3):18748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Salazar X, Núnez-Curto A, Villayzán J, et al. How Peru introduced a plan for comprehensive HIV prevention and care for transwomen. J Int AIDS Soc. 2016;19(3 suppl 2):20790. [DOI] [PMC free article] [PubMed] [Google Scholar]